Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E0M |
Peritoneal Cavity
|
3E0M0 |
Open
|
3E0M05 |
Adhesion Barrier
|
3E0M05Z
|
No Qualifier
Introduction of Adhesion Barrier into Peritoneal Cavity, Open Approach
|
3E0M3 |
Percutaneous
|
3E0M30 |
Antineoplastic
|
3E0M304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach
|
3E0M305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach
|
3E0M30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach
|
3E0M30Y
|
Hyperthermic
Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach
|
3E0M32 |
Anti-infective
|
3E0M328
|
Oxazolidinones
Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach
|
3E0M329
|
Other Anti-infective
Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach
|
3E0M33 |
Anti-inflammatory
|
3E0M33Z
|
No Qualifier
Introduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach
|
3E0M35 |
Adhesion Barrier
|
3E0M35Z
|
No Qualifier
Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Approach
|
3E0M36 |
Nutritional Substance
|
3E0M36Z
|
No Qualifier
Introduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach
|
3E0M37 |
Electrolytic and Water Balance Substance
|
3E0M37Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach
|
3E0M3B |
Anesthetic Agent
|
3E0M3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach
|
3E0M3G |
Other Therapeutic Substance
|
3E0M3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach
|
3E0M3H |
Radioactive Substance
|
3E0M3HZ
|
No Qualifier
Introduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach
|
3E0M3K |
Other Diagnostic Substance
|
3E0M3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach
|
3E0M3N |
Analgesics, Hypnotics, Sedatives
|
3E0M3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach
|
3E0M3S |
Gas
|
3E0M3SF
|
Other Gas
Introduction of Other Gas into Peritoneal Cavity, Percutaneous Approach
|
3E0M3T |
Destructive Agent
|
3E0M3TZ
|
No Qualifier
Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach
|
3E0M4 |
Percutaneous Endoscopic
|
3E0M45 |
Adhesion Barrier
|
3E0M45Z
|
No Qualifier
Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Endoscopic Approach
|
3E0M4G |
Other Therapeutic Substance
|
3E0M4GC
|
Other Substance
Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Endoscopic Approach
|
3E0M7 |
Via Natural or Artificial Opening
|
3E0M70 |
Antineoplastic
|
3E0M704
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening
|
3E0M705
|
Other Antineoplastic
Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening
|
3E0M70M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening
|
3E0M7S |
Gas
|
3E0M7SF
|
Other Gas
Introduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening
|